Figure 1. Kaplan-Meier Curve of Relapse-free Survival (FAS).

RFS was defined as the time from the date of CR1 to the date of relapse (per IWG response criteria for AML) or death due to any cause through the date cut-off of 10 February 2017. Dose level cohorts are indicated. FAS: full analysis set.